午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook--->CAS DataBase List--->175215-34-6

175215-34-6

175215-34-6 Structure

175215-34-6 Structure
IdentificationBack Directory
[Name]

1-Propanesulfonamide, 2,2-dimethyl-3-[[7-(1-methylethyl)[1,2,4]triazolo[1,5-b]pyridazin-6-yl]oxy]-
[CAS]

175215-34-6
[Synonyms]

1-Propanesulfonamide, 2,2-dimethyl-3-[[7-(1-methylethyl)[1,2,4]triazolo[1,5-b]pyridazin-6-yl]oxy]-
[Molecular Formula]

C13H21N5O3S
[MOL File]

175215-34-6.mol
[Molecular Weight]

327.4
Chemical PropertiesBack Directory
[density ]

1.39±0.1 g/cm3(Predicted)
[pka]

10.49±0.60(Predicted)
Hazard InformationBack Directory
[Uses]

TAK-661 is a inhibitor of eosinophil chemotaxis. TAK-661 significantly reduces the bronchoconstriction during the late phase, along with the inhibition of eosinophilia in bronchoalveolar lavage (BAL) and the eosinophil infiltration into the airway wall[1].
[References]

[1] K Fujimoto, et al. Effects of an eosinophil chemotaxis inhibitor, TAK-661, on antigen-induced asthmatic responses in allergic sheep. Lung. 2002;180(3):161-72. DOI:10.1007/s004080000090
175215-34-6 suppliers list
Company Name: Suzhou Meishi Biotechnology Co., Ltd.  
Tel: 1173954148q
Website: www.yuhua99.com/ShowSupplierProductsList1822805/0_EN.htm
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Tags:175215-34-6 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.